Why are homocysteine levels increased in kidney failure? A metabolic approach.
Blom
Henk J
HJ
Department of Pediatrics, University Hospital Nijmegen, The Netherlands. h.blom@ckslkn.azn.nl
De Vriese
An S
AS
De Vriese
S
S
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000378:metabolism; D050940:Betaine-Homocysteine S-Methyltransferase; D004220:Disulfides / Q000378:metabolism; D006710:Homocysteine / Q000097:blood* / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000378:metabolism; D008715:Methionine / Q000378:metabolism; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008780:Methyltransferases / Q000378:metabolism; D010084:Oxidation-Reduction; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000378:metabolism; D051437:Renal Insufficiency / Q000097:blood*
D004220:Disulfides; D006710:Homocysteine; D008715:Methionine; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008780:Methyltransferases; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; C494548:BHMT protein, human; D050940:Betaine-Homocysteine S-Methyltransferase